148 related articles for article (PubMed ID: 23065569)
1. VEGF-C expression in oral cancer by neurotransmitter-induced activation of beta-adrenergic receptors.
Vilardi BM; Bravo-Calderón DM; Bernabé DG; Oliveira SH; Oliveira DT
Tumour Biol; 2013 Feb; 34(1):139-43. PubMed ID: 23065569
[TBL] [Abstract][Full Text] [Related]
2. Expression of beta2-adrenergic receptor in oral squamous cell carcinoma.
Shang ZJ; Liu K; Liang DF
J Oral Pathol Med; 2009 Apr; 38(4):371-6. PubMed ID: 19141064
[TBL] [Abstract][Full Text] [Related]
3. Beta adrenergic receptor activation inhibits oral cancer migration and invasiveness.
Bravo-Calderón DM; Assao A; Garcia NG; Coutinho-Camillo CM; Roffé M; Germano JN; Oliveira DT
Arch Oral Biol; 2020 Oct; 118():104865. PubMed ID: 32801034
[TBL] [Abstract][Full Text] [Related]
4. Propranolol inhibits cell viability and expression of the pro-tumorigenic proteins Akt, NF-ĸB, and VEGF in oral squamous cell carcinoma.
Shibuya CM; Tjioe KC; Oliveira SHP; Bernabé DG
Arch Oral Biol; 2022 Apr; 136():105383. PubMed ID: 35240444
[TBL] [Abstract][Full Text] [Related]
5. Effect of Stimulation of Neurotransmitter Systems on Heart Rate Variability and β-Adrenergic Responsiveness of Erythrocytes in Outbred Rats.
Kur'yanova EV; Tryasuchev AV; Stupin VO; Teplyi DL
Bull Exp Biol Med; 2017 May; 163(1):31-36. PubMed ID: 28577106
[TBL] [Abstract][Full Text] [Related]
6. Norepinephrine-induced invasion by pancreatic cancer cells is inhibited by propranolol.
Guo K; Ma Q; Wang L; Hu H; Li J; Zhang D; Zhang M
Oncol Rep; 2009 Oct; 22(4):825-30. PubMed ID: 19724861
[TBL] [Abstract][Full Text] [Related]
7. Norepinephrine-Induced Stimulation of Kir4.1/Kir5.1 Is Required for the Activation of NaCl Transporter in Distal Convoluted Tubule.
Duan XP; Gu L; Xiao Y; Gao ZX; Wu P; Zhang YH; Meng XX; Wang JL; Zhang DD; Lin DH; Wang WH; Gu R
Hypertension; 2019 Jan; 73(1):112-120. PubMed ID: 30571558
[TBL] [Abstract][Full Text] [Related]
8. Prediction of outcome of patients with oral squamous cell carcinoma using vascular invasion and the strongly positive expression of vascular endothelial growth factors.
Seki S; Fujiwara M; Matsuura M; Fujita S; Ikeda H; Asahina I; Ikeda T
Oral Oncol; 2011 Jul; 47(7):588-93. PubMed ID: 21602095
[TBL] [Abstract][Full Text] [Related]
9. β-Adrenergic receptors (β-AR) regulate VEGF and IL-6 production by divergent pathways in high β-AR-expressing breast cancer cell lines.
Madden KS; Szpunar MJ; Brown EB
Breast Cancer Res Treat; 2011 Dec; 130(3):747-58. PubMed ID: 21234673
[TBL] [Abstract][Full Text] [Related]
10. Beta-adrenergic blocker inhibits oral carcinogenesis and reduces tumor invasion.
Cecilio HP; Valente VB; Pereira KM; Kayahara GM; Furuse C; Biasoli ÉR; Miyahara GI; Oliveira SHP; Bernabé DG
Cancer Chemother Pharmacol; 2020 Nov; 86(5):681-686. PubMed ID: 32980903
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous expression of furin and vascular endothelial growth factor in human oral tongue squamous cell carcinoma progression.
López de Cicco R; Watson JC; Bassi DE; Litwin S; Klein-Szanto AJ
Clin Cancer Res; 2004 Jul; 10(13):4480-8. PubMed ID: 15240540
[TBL] [Abstract][Full Text] [Related]
12. Lipopolysaccharide-squamous cell carcinoma-monocyte interactions induce cancer-supporting factors leading to rapid STAT3 activation.
Kurago ZB; Lam-ubol A; Stetsenko A; De La Mater C; Chen Y; Dawson DV
Head Neck Pathol; 2008 Mar; 2(1):1-12. PubMed ID: 19603082
[TBL] [Abstract][Full Text] [Related]
13. WISP-1 promotes VEGF-C-dependent lymphangiogenesis by inhibiting miR-300 in human oral squamous cell carcinoma cells.
Lin CC; Chen PC; Lein MY; Tsao CW; Huang CC; Wang SW; Tang CH; Tung KC
Oncotarget; 2016 Mar; 7(9):9993-10005. PubMed ID: 26824419
[TBL] [Abstract][Full Text] [Related]
14. Role of the adrenergic system in a mouse model of oxygen-induced retinopathy: antiangiogenic effects of beta-adrenoreceptor blockade.
Ristori C; Filippi L; Dal Monte M; Martini D; Cammalleri M; Fortunato P; la Marca G; Fiorini P; Bagnoli P
Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):155-70. PubMed ID: 20739470
[TBL] [Abstract][Full Text] [Related]
15. Novel DOX-MTX nanoparticles improve oral SCC clinical outcome by down regulation of lymph dissemination factor VEGF-C expression in vivo: oral and IV modalities.
Abbasi MM; Monfaredan A; Hamishehkar H; Seidi K; Jahanban- Esfahlan R
Asian Pac J Cancer Prev; 2014; 15(15):6227-32. PubMed ID: 25124602
[TBL] [Abstract][Full Text] [Related]
16. [Expression of vascular endothelial growth factor, vascular endothelial growth factor receptor-3 and nm23-H1 in oral squamous cell carcinoma].
Xu JC; Feng ZZ; Zhao SF
Zhonghua Kou Qiang Yi Xue Za Zhi; 2007 Nov; 42(11):681-3. PubMed ID: 18307927
[TBL] [Abstract][Full Text] [Related]
17. Roles of VEGF-Flt-1 signaling in malignant behaviors of oral squamous cell carcinoma.
Subarnbhesaj A; Miyauchi M; Chanbora C; Mikuriya A; Nguyen PT; Furusho H; Ayuningtyas NF; Fujita M; Toratani S; Takechi M; Niida S; Takata T
PLoS One; 2017; 12(11):e0187092. PubMed ID: 29149180
[TBL] [Abstract][Full Text] [Related]
18. The stress hormone norepinephrine promotes tumor progression through β2-adrenoreceptors in oral cancer.
Zhang B; Wu C; Chen W; Qiu L; Li S; Wang T; Xie H; Li Y; Li C; Li L
Arch Oral Biol; 2020 May; 113():104712. PubMed ID: 32234582
[TBL] [Abstract][Full Text] [Related]
19. Expression of vascular endothelial growth factor A, B, C, and D in oral squamous cell carcinoma.
Shintani S; Li C; Ishikawa T; Mihara M; Nakashiro K; Hamakawa H
Oral Oncol; 2004 Jan; 40(1):13-20. PubMed ID: 14662410
[TBL] [Abstract][Full Text] [Related]
20. Norepinephrine promotes the β1-integrin-mediated adhesion of MDA-MB-231 cells to vascular endothelium by the induction of a GROα release.
Strell C; Niggemann B; Voss MJ; Powe DG; Zänker KS; Entschladen F
Mol Cancer Res; 2012 Feb; 10(2):197-207. PubMed ID: 22127496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
